Section Arrow
Quote
IMDX.NASDAQ
- Insight Molecular Diagnostics Inc
Quotes are at least 15-min delayed:2026/02/12 08:11 EST
Pre Market
Last
 5.7
-0.03 (-0.52%)
Bid
3.5
Ask
6.25
High 6 
Low 5.7 
Volume 177 
Regular Hours (Closed)
Last
 5.73
-1.68 (-22.67%)
Day High 
6.37 
Prev. Close
7.41 
1-M High
7.51 
Volume 
439.67K 
Bid
3.5
Ask
6.25
Day Low
5.225 
Open
6.105 
1-M Low
6.04 
Market Cap 
212.40M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 6.88 
20-SMA 6.77 
50-SMA 6.32 
52-W High 8.51 
52-W Low 2.3205 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.21/-0.31
Enterprise Value
214.77M
Balance Sheet
Book Value Per Share
-0.32
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.88M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IQVIQVIA Holdings177.18-5.27-2.89%24.37PE
Pre Market 163.9 -13.28 -7.50%
DHRDanaher Corp219.98+0.23+0.10%45.39PE
Pre Market 219.61 -0.37 -0.17%
WATWaters Corp329.2+2.18+0.67%30.26PE
Pre Market 331.555 +2.355 +0.72%
NEOGNeogen Corp10.75+0.02+0.19%-- 
Pre Market 10.66 -0.09 -0.84%
ICLRICON plc133.14-11.41-7.89%17.94PE
Pre Market 95.74 -37.4 -28.09%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.